Oropharyngeal Administration of Colostrum Increases Salivary Secretory IgA Levels in Very Low-Birth-Weight Infants

American Journal of Perinatology

Volumn 34, Issue 14, 2017, Pages 1389-1395

  Glass, Kristen M ^a   Greecher, Coleen P ^b   Doheny, Kim K ^a,b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

colostrum; infection; salivary secretory IgA; VLBW infant

Indexed keywords

SECRETORY IMMUNOGLOBULIN; STERILE WATER;

ARTICLE; CLINICAL ARTICLE; COLOSTRUM; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN SEPSIS; OROPHARYNX; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SALIVA LEVEL; VERY LOW BIRTH WEIGHT; IMMUNOLOGY; METABOLISM; MULTIVARIATE ANALYSIS; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PREGNANCY; PREMATURITY; PROCEDURES; SALIVA; STATISTICAL MODEL;

COLOSTRUM; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE, NEONATAL; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NEONATAL SEPSIS; OROPHARYNX; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; PREGNANCY; PROSPECTIVE STUDIES; SALIVA;

EID: 85020245471     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0037-1603655     Document Type: Article

References (30)

1. Stoll B. J. Hansen N. Fanaroff A. A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics: 2002; 110 (2 Pt 1): 285 291
2. Furman L. Taylor G. Minich N. Hack M. The effect of maternal milk on neonatal morbidity of very low-birth-weight infants. Arch Pediatr Adolesc Med: 2003; 157 01 66 71
3. Schanler R. J. Shulman R. J. Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics: 1999; 103 (6 Pt 1): 1150 1157
4. Buescher E. S. Anti-inflammatory characteristics of human milk: how, where, why. Adv Exp Med Biol: 2001; 501 207 222
5. Garofalo R. P. Goldman A. S. Cytokines, chemokines, and colony-stimulating factors in human milk: the 1997 update. Biol Neonate: 1998; 74 02 134 142
6. Araújo E. D. Gonçalves A. K. Cornetta MdaC., et al. Evaluation of the secretory immunoglobulin A levels in the colostrum and milk of mothers of term and pre-term newborns. Braz J Infect Dis: 2005; 9 05 357 362
7. Koenig A. de Albuquerque Diniz E. M. Barbosa S. F. Vaz F. A. Immunologic factors in human milk: the effects of gestational age and pasteurization. J Hum Lact: 2005; 21 04 439 443
8. Westerbeek E. A. van den Berg A. Lafeber H. N. Knol J. Fetter W. P. van Elburg R. M. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr: 2006; 25 03 361 368
9. Rodriguez N. A. Meier P. P. Groer M. W. Zeller J. M. Oropharyngeal administration of colostrum to extremely low birth weight infants: theoretical perspectives. J Perinatol: 2009; 29 01 1 7
10. Eid P. Meritet J. F. Maury C. Lasfar A. Weill D. Tovey M. G. Oromucosal interferon therapy: pharmacokinetics and pharmacodynamics. J Interferon Cytokine Res: 1999; 19 02 157 169
11. Lecciones J. A. Abejar N. H. Dimaano E. E., et al. A pilot double-blind, randomized, and placebo-controlled study of orally administered IFN-alpha-n1 (Ins) in pediatric patients with measles. J Interferon Cytokine Res: 1998; 18 09 647 652
12. Tovey M. G. Meritet J. F. Guymarho J. Maury C. Mucosal cytokine therapy: marked antiviral and antitumor activity. J Interferon Cytokine Res: 1999; 19 08 911 921
13. Bocci V. von Bremen K. Corradeschi F. Luzzi E. Paulesu L. What is the role of cytokines in human colostrum? J Biol Regul Homeost Agents: 1991; 5 04 121 124
14. Field C. J. The immunological components of human milk and their effect on immune development in infants. J Nutr: 2005; 135 01 1 4
15. Ogawa J. Sasahara A. Yoshida T., et al. Role of transforming growth factor-beta in breast milk for initiation of IgA production in newborn infants. Early Hum Dev: 2004; 77 (1-2): 67 75
16. Goldblum R. M. Schanler R. J. Garza C. Goldman A. S. Human milk feeding enhances the urinary excretion of immunologic factors in low birth weight infants. Pediatr Res: 1989; 25 02 184 188
17. Schanler R. J. Goldblum R. M. Garza C. Goldman A. S. Enhanced fecal excretion of selected immune factors in very low birth weight infants fed fortified human milk. Pediatr Res: 1986; 20 08 711 715
18. Neu M. Goldstein M. Gao D. Laudenslager M. L. Salivary cortisol in preterm infants: Validation of a simple method for collecting saliva for cortisol determination. Early Hum Dev: 2007; 83 01 47 54
19. Lee J. Kim H. S. Jung Y. H., et al. Oropharyngeal colostrum administration in extremely premature infants: an RCT. Pediatrics: 2015; 135 02 e357 e366
20. Rodriguez N. A. Meier P. P. Groer M. W. Zeller J. M. Engstrom J. L. Fogg L. A pilot study to determine the safety and feasibility of oropharyngeal administration of own mother's colostrum to extremely low-birth-weight infants. Adv Neonatal Care: 2010; 10 04 206 212
21. Montgomery D. Baer V. Lambert D. Christensen R. Oropharyngeal administration of colostrum to very low birth weight infants: results of a feasibility trial. Neonatal Intensive Care: 2010; 23 27 29
22. Gephart S. M. Weller M. Colostrum as oral immune therapy to promote neonatal health. Adv Neonatal Care: 2014; 14 01 44 51
23. Spencer J. Macdonald T. T. Ontogeny of human mucosal immunity. In: Macdonald T. T., ed. Ontogeny of the Immune System of the Gut. Boca Raton, FL CRC Press: 1990; 23 50
24. Stoll B. J. Lee F. K. Hale E., et al. Immunoglobulin secretion by the normal and the infected newborn infant. J Pediatr: 1993; 122 (5 Pt 1): 780 786
25. Ng P. C. Li K. Wong R. P., et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed: 2003; 88 03 F209 F213
26. Kadaoui K. A. Corthésy B. Secretory IgA mediates bacterial translocation to dendritic cells in mouse Peyer's patches with restriction to mucosal compartment. J Immunol: 2007; 179 11 7751 7757
27. Corthésy B. Role of secretory IgA in infection and maintenance of homeostasis. Autoimmun Rev: 2013; 12 06 661 665
28. Rodriguez N. A. Groer M. W. Zeller J. M. A randomized, controlled trial of the oropharyngeal administration of mother's colostrum to extremely low birth weight infants in the first few days of life. Neonatal Intensive Care: 2011; 24 04 31 35
29. Seigel J. K. Smith P. B. Ashley P. L., et al. Early administration of oropharyngeal colostrum to extremely low birth weight infants. Breastfeed Med: 2013; 8 06 491 495
30. Rodriguez N. A. Vento M. Claud E. C. Wang C. E. Caplan M. S. Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial. Trials: 2015; 16 01 453. Doi: 10.1186/s13063-015-0969-6